Home
About
Overview
Sharing Data
ORCID
Help
History (6)
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).
Fragile X: leading the way for targeted treatments in autism.
Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome.
Neuropathic features in fragile X premutation carriers.
Descriptive analysis of seizures and comorbidities associated with fragile X syndrome.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Descriptive analysis of seizures and comorbidities associated with fragile X syndrome.
Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. Mol Genet Genomic Med. 2022 08; 10(8):e2001.
View in:
PubMed
subject areas
Autism Spectrum Disorder
Comorbidity
Fragile X Mental Retardation Protein
Fragile X Syndrome
Humans
Mitral Valve Prolapse
Seizures
authors with profiles
Elizabeth M Berry-Kravis